awaiting safety review
To simplify the process, the MIT team wanted to come up with a way to generate CAR NK cells "in vivo"—that is, in the patient's own body, without having to remove any cells.
To simplify the process, the MIT team wanted to come up with a way to generate CAR NK cells "in vivo"—that is, in the patient's own body, without having to remove any cells.